The association between blood CK20 mRNA detection and survival for patients with UICC stages I and II was not significant for overall survival (p = 0.512), recurrence-free survival (p = 0.582) and tumor-specific survival (p = 0.597) (Figure 3A). The gene discussed is KRT20; the disease is neoplasm.